Lower T cell response against SARS-CoV-2 variants of concern after mRNA vaccine and risk of breakthrough infections in people living with HIV. Casado JL, Vizcarra P, Martin-Colmenarejo S, Del Pino J, et al. AIDS 2023 Feb 8. doi: 10.1097/QAD.0000000000003504.

Read + Share

Amedeo Smart

Independent Medical Education